Tianjin Chase Sun Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
340,897.50
448,935.40
536,234.40
661,075.60
447,206.70
215,912
Depreciation, Depletion & Amortization
44,730.10
52,005.90
61,519.30
100,259.90
113,684.40
139,468.80
Other Funds
1,855.90
145,496.80
909,155.10
16,973.20
18,988.50
344,454.30
Funds from Operations
403,506.90
499,821.80
641,013.10
806,252.30
707,290.40
683,087.10
Changes in Working Capital
262,726.00
343,580.50
507,606.90
353,675.30
36,957.00
293,773.40
Net Operating Cash Flow
140,780.90
156,241.40
133,406.20
452,577.10
744,247.50
389,313.70
Capital Expenditures
107,197.40
178,373.60
223,353.80
415,524.60
373,172.00
Sale of Fixed Assets & Businesses
1,601.80
568.80
98,810.70
447.20
16,767.30
Purchase/Sale of Investments
86,243.20
17,034.30
47,158.30
189,291.70
114,393.20
Net Investing Cash Flow
191,838.80
160,770.40
135,303.10
610,137.70
479,428.50
Cash Dividends Paid - Total
24,931.50
38,202.00
60,768.80
60,267.20
75,276.40
Issuance/Reduction of Debt, Net
33,500.00
114,500.00
6,493.40
160,543.70
240,642.70
Net Financing Cash Flow
56,575.60
221,794.80
841,892.90
117,249.70
334,907.50
Net Change in Cash
107,645.20
217,267.10
840,667.50
40,128.60
82,255.40
Free Cash Flow
33,583.50
22,132.20
89,947.60
37,052.50
371,075.50
Deferred Taxes & Investment Tax Credit
2,704.30
22,830.60
6,109.90
2,297.90
2,537.70
16,748
Net Assets from Acquisitions
-
-
57,918.30
5,768.50
8,630.60
Exchange Rate Effect
11.70
1.40
671.50
182.30
12,166.90
About Tianjin Chase Sun Pharmaceutical Co.
View Profile
